Skip to main content
TipRanks
Go Ultimate75% OFF

Starpharma Holdings Limited (PQ6) AI Stock Analysis

0 Followers
DE:PQ6

Starpharma Holdings Limited

(Frankfurt:PQ6)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Dendrimer technology platformStarpharma’s dendrimer platform provides a focused technological foundation across pharmaceuticals, topical products and other healthcare applications. A reusable platform can support multiple development and licensing opportunities, giving the company a broader strategic base than a single-product business.
Negative Factors
Persistent operating lossesStarpharma remains materially loss-making despite generating A$10.4m of gross profit in 2026. Continued negative EBIT, EBITDA and net income indicate that the current business model has not yet converted commercial activity into sustainable operating profitability.

Starpharma Holdings Limited (PQ6) vs. iShares MSCI Germany ETF (EWG)

-50%0%50%100%150%200%DE:PQ6+21.21%EWG+6.23%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 154.53M
Dividend Yield
―
Average Volume (3M)
8,898
Price to Earnings (P/E)
-24.3
Beta (1Y)
1.39
Revenue Growth
134.40%
EPS Growth
24.46%
Country
Germany
Employees
50
Sector
Healthcare
Sector Strength
51
Industry
Biotechnology

Starpharma Holdings Limited Business Overview & Revenue Model

Company Description

Starpharma Holdings Limited is a biopharmaceutical enterprise focused on the research, development, and global commercialization of dendrimer-based products for the pharmaceutical, life sciences, and other industries. Its current offerings include Vi...

Starpharma Holdings Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:PQ6 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
AU:IMMAU:IMM50NeutralAUD 33.90M-0.46-98.86%――-27.73%
AU:RCEAU:RCE46NeutralAUD 113.19M-7.1484.67%――42.51%
AU:DXBAU:DXB43NeutralAUD 111.07M-3.82362.74%―-22.13%-108.82%
AU:BOTAU:BOT38UnderperformAUD 27.63M-0.28-118.74%―499.47%31.20%
AU:ADOAU:ADO31UnderperformAUD 55.55M-11.43-77.75%―-51.74%24.00%

* Healthcare Sector Average

Performance Comparison

0%100%DE:PQ6AU:IMMAU:DXBAU:ADOAU:BOTAU:RCEDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:PQ6 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:PQ6Starpharma Holdings Limited0.240.0422.45%
AU:IMMImmutep Ltd0.02-0.24-91.15%
AU:DXBDimerix Limited0.18-0.28-59.78%
AU:ADOAnteoTech Ltd0.02-0.00-5.56%
AU:BOTBotanix Pharmaceuticals Limited0.01-0.11-91.67%
AU:RCERecce Pharmaceuticals Ltd.0.37-0.05-12.94%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.